The first drug to treat infants sick with malaria is approved by Swiss authority
Headline from KOB 4
Switzerland’s medical products authority has granted the first approval for a malaria medicine designed for small infants. It's billed as an advance against a disease that takes hundreds of thousands of lives each year. Nearly all of the deaths are in Africa.
KOB 4's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Switzerland’s medical products authority has granted the first approval for a malaria medicine designed for small infants. It's billed as an advance against a disease that takes hundreds of thousands of lives each year. Nearly all of the deaths are in Africa.
GENEVA -- Switzerland's medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as an advance against a disease that takes hundreds of thousands of lives -- nearly all in Africa -- each year.
The approval of the first malaria treatment for newborns and young infants could lead to imminent widespread use in Africa, drugmaker Novartis said Tuesday.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
The first drug to treat infants sick with malaria is approved by Swiss authority | Since Then
